Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Skinmed
|
March 20, 2018
Coccidioidomycosis
Matthew Laffer, Lindsay Ackerman
Journal of Medical Case Reports
|
November 3, 2020
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report
Ivorie Coleman, Gabriel Ruiz, Sumir Brahmbhatt, et al.
Cureus
|
May 19, 2025
Drug-Induced Leukocytoclastic Vasculitis From an Unreported Source: Daptomycin
Jennifer K Priessnitz, Timothy Kuzel, Lindsay Ackerman, et al.
Cureus
|
April 17, 2023
Langerhans Cell Histiocytosis Presenting With Clinical Features of Hidradenitis Suppurativa
Miranda L Yousif, Claire S Faulkner, Lise Harper, et al.
JAMA Dermatology
|
November 16, 2022
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology
Yi Gao, Travis Fulk, Westley Mori, et al.
Journal of Drugs in Dermatology : JDD
|
May 4, 2026
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
Brooke Bartley, Angela Rosenberg, Lauren DeBusk, et al.
JAMA Dermatology
|
March 18, 2026
Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial
Alexa B Kimball, Konrad T Sawicki, Lindsay Ackerman, et al.
Dermatology and Therapy
|
October 26, 2025
Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16
Eingun James Song, Benjamin Ehst, Brad Glick, et al.
Dermatology and Therapy
|
January 19, 2026
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study
Jonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, et al.
Nature Medicine
|
November 13, 2023
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial
Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Skinmed
|
March 20, 2018
Coccidioidomycosis
Matthew Laffer, Lindsay Ackerman
Journal of Medical Case Reports
|
November 3, 2020
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report
Ivorie Coleman, Gabriel Ruiz, Sumir Brahmbhatt, et al.
Cureus
|
May 19, 2025
Drug-Induced Leukocytoclastic Vasculitis From an Unreported Source: Daptomycin
Jennifer K Priessnitz, Timothy Kuzel, Lindsay Ackerman, et al.
Cureus
|
April 17, 2023
Langerhans Cell Histiocytosis Presenting With Clinical Features of Hidradenitis Suppurativa
Miranda L Yousif, Claire S Faulkner, Lise Harper, et al.
JAMA Dermatology
|
November 16, 2022
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology
Yi Gao, Travis Fulk, Westley Mori, et al.
Journal of Drugs in Dermatology : JDD
|
May 4, 2026
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
Brooke Bartley, Angela Rosenberg, Lauren DeBusk, et al.
JAMA Dermatology
|
March 18, 2026
Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial
Alexa B Kimball, Konrad T Sawicki, Lindsay Ackerman, et al.
Dermatology and Therapy
|
October 26, 2025
Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16
Eingun James Song, Benjamin Ehst, Brad Glick, et al.
Dermatology and Therapy
|
January 19, 2026
Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study
Jonathan I Silverberg, Lindsay Ackerman, Jerry Bagel, et al.
Nature Medicine
|
November 13, 2023
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial
Lindsay Ackerman, Gerard Acloque, Sandro Bacchelli, et al.
Page
of 1